In studies with recombinant factor VIII preparations, development of inhibitors is predominantly observed in previously untreated haemophiliacs.
En estudios con preparados de factor VIII recombinante, el desarrollo de inhibidores se observó principalmente en pacientes hemofílicos no tratados previamente.